Pharmaceutical Clean Room Design:
ISO 14644 Classification,
EU GMP Grades & HVAC Validation
Pharmaceutical clean rooms are not just classified spaces — they are validated environments. The bridge between ISO 14644 and EU GMP Grade A/B/C/D is the HVAC validation protocol, not the specification sheet.
The terms ISO 14644 and EU GMP Grade A/B/C/D appear in almost every pharmaceutical clean room specification. They are often treated as synonyms — they are not. ISO 14644 classifies clean rooms by airborne particulate concentration. EU GMP classifies pharmaceutical manufacturing environments by their contamination control requirements for specific process activities. The relationship between the two is defined in regulatory guidance — and understanding it is the starting point for any pharmaceutical HVAC design.
A clean room that achieves ISO 5 classification in a particle count test has met a particulate concentration limit. It may or may not be adequate for the GMP Grade A activity it is intended to support, depending on air change rate, pressure differentials, personnel gowning, environmental monitoring programme, and the validation evidence behind it. Getting this right requires understanding both classification systems and the bridge between them — the HVAC validation protocol.
ISO 14644 vs EU GMP Classification: Understanding Both
ISO 14644-1 defines clean room classification based on the concentration of airborne particles at specified sizes. The classification is expressed as ISO Class N, where the maximum particle concentration at 0.1 µm equals 10^N particles/m³.
| ISO Class | Max particles ≥0.5 µm/m³ | Max particles ≥5 µm/m³ | EU GMP Grade (at rest) | EU GMP Grade (in operation) | Typical Application |
|---|---|---|---|---|---|
| ISO 5 | 3,520 | 29 | A | A | Aseptic filling; open product/container exposure |
| ISO 6 | 35,200 | 293 | B | — | Background to ISO 5 in aseptic areas |
| ISO 7 | 352,000 | 2,930 | C | B | Sterile product preparation; background to aseptic filling |
| ISO 8 | 3,520,000 | 29,300 | D | C | Component preparation; less critical stages |
| ISO 8 (controlled) | — | — | — | D | Primary packaging; general controlled environment |
The at-rest vs in-operation distinction: EU GMP defines Grade limits for both ‘at rest’ (no personnel, equipment static) and ‘in operation’ (during actual production with full personnel complement). The HVAC system must achieve the classification ‘at rest’ — but the facility design must ensure that the ‘in operation’ grade is also maintained, accounting for particle generation by personnel and process activities. An HVAC system verified at rest but not validated in operation provides incomplete qualification evidence.
HVAC Design Requirements by GMP Grade
Each GMP Grade has specific HVAC requirements that go beyond particle count — pressure differentials, air change rates, temperature and humidity limits, and air distribution design.
Grade A — Unidirectional Flow
EU GMP Annex 1 (2022) requires Grade A to be provided by a unidirectional airflow (UDAF) system — supply air moves in a single, parallel direction across the work zone at 0.36–0.54 m/s face velocity. This ‘pushes’ particles away from the product rather than mixing them. HEPA H14 terminal filtration (≥99.995% efficiency). Temperature 18–22°C, RH 30–65%.
Grade B — Background to Grade A
Grade B provides the controlled environment immediately surrounding the Grade A zone. Turbulent mixing ventilation with HEPA H13 terminal filtration. Minimum 20 ACH. Positive pressure cascade: Grade A > Grade B > Grade C > Grade D > corridor. Pressure differential: minimum 10–15 Pa between adjacent grades.
Grade C — Non-Aseptic Sterile Preparation
Turbulent ventilation, minimum 20 ACH, HEPA H13 filtration. Used for preparation of solutions that will be sterile-filtered, preparation of components for aseptic assembly. Temperature and humidity controlled. Gowning procedure required.
Grade D — Less Critical Activities
Minimum 6–10 ACH, HEPA H13 or H11 filtration depending on product risk. Primary packaging of oral solid dosage, component preparation, general controlled environment. Temperature and humidity controlled within specified limits.
EU GMP Annex 1 (2022): Key Changes for HVAC Design
The 2022 revision of EU GMP Annex 1 (Manufacturing of Sterile Medicinal Products) introduced significant changes to clean room design and validation requirements. Facilities designed to the previous 2008 version may have compliance gaps under the 2022 requirements.
- 01
Contamination Control Strategy (CCS)
Annex 1 (2022) requires a documented Contamination Control Strategy — a holistic assessment of all contamination risks and controls across the entire manufacturing process. The HVAC system’s role within the CCS must be explicitly defined and justified. HVAC is no longer a standalone validation exercise; it is a component of the facility-wide contamination control framework.
- 02
UDAF Velocity Verification
Annex 1 (2022) specifies a velocity range of 0.36–0.54 m/s for unidirectional airflow in Grade A zones, measured at the work plane. The validation must demonstrate uniform velocity across the full protected zone — not just at the centre of the UDAF unit. CFD modelling is recommended for complex zone geometries.
- 03
Smoke Visualisation Studies
Annex 1 (2022) requires smoke visualisation studies to demonstrate that the UDAF airflow pattern actually protects the product — that smoke introduced at personnel positions and process equipment does not enter the critical zone. This must be conducted at maximum personnel and process loading, not in an idealised empty room.
- 04
Environmental Monitoring (EM) Programme
The Annex 1 (2022) EM programme requirements are more prescriptive than the 2008 version — specific sampling frequencies, particle count locations at risk-based positions, action and alert limits, and data trending. The EM programme design must be integrated with HVAC design — sensor and sample point locations defined during design, not as an afterthought.
- 05
Ongoing Performance Verification
Annex 1 (2022) requires ongoing monitoring of HVAC performance, not just qualification at initial installation. Airflow rate, pressure differentials, temperature, and humidity must be continuously monitored. BMS alarms for out-of-specification conditions must be defined and their response documented in operating procedures.
NABH and Indian regulatory alignment: Indian pharmaceutical facilities selling to regulated markets (US FDA 21 CFR, EMA, MHRA) must comply with the relevant foreign regulatory HVAC requirements in addition to Schedule M (Good Manufacturing Practices under the Drugs and Cosmetics Act). NABH accreditation for hospital pharmacy is separate from GMP requirements. Where facilities must satisfy both Indian and foreign regulatory requirements, the more stringent requirement governs.
HVAC Validation Protocol for GMP Facilities
HVAC qualification in a GMP pharmaceutical facility follows the IQ/OQ/PQ framework with pharmaceutical-specific test protocols.
| Qualification Stage | Key Tests | Standards Referenced |
|---|---|---|
| IQ | Equipment installation verification; as-built drawing check; filter certification; instrument calibration | ISPE HVAC Guide; ISO 14644-4 |
| OQ | Airflow rate measurement; pressure differential mapping; temperature and humidity mapping; HEPA filter integrity test (DOP/PAO); smoke visualisation; alarm and interlock function test | ISO 14644-3; EU GMP Annex 1 (2022) |
| PQ | Particle count classification testing (at rest and in operation); viable particle sampling; pressure cascade stability over time; recovery time test after excursion | ISO 14644-1; EU GMP Annex 1 |
| Ongoing | Continuous BMS monitoring; periodic requalification (annually minimum); change control qualification for any HVAC modification | EU GMP Chapter 3; Schedule M |
The KVRM Pharmaceutical Clean Room Design Approach
- 01
GMP Grade Zoning
Product risk assessment and GMP grade assignment for every manufacturing space — based on process activity, product exposure, and sterility requirement. Grade zoning defines pressure cascade, gowning requirement, and HVAC specification for each zone.
- 02
HVAC System Design
UDAF system design for Grade A (velocity uniformity, filter coverage, turbulence intensity). AHU design for Grades B/C/D — recirculation ratio, supply/return arrangement, HEPA filter specification. Pressure cascade design — differential pressure between each grade and adjacent spaces.
- 03
CFD Airflow Validation
Computational Fluid Dynamics modelling for Grade A UDAF zones — velocity profile, smoke visualisation prediction, worst-case personnel loading scenarios. CFD results reviewed against Annex 1 (2022) requirements before physical installation.
- 04
Validation Protocol Development
IQ/OQ/PQ protocol developed referencing EU GMP Annex 1 (2022), ISO 14644-3, and ISPE HVAC Guide. EM programme design with risk-based sample point locations, frequencies, and alert/action limits.
- 05
Regulatory Submission Support
Design documentation prepared in the format required for Drug Controller General of India (DCGI) manufacturing licence applications, WHO GMP audits, and foreign regulatory agency (US FDA, EMA) inspections.
Conclusion: Pharmaceutical HVAC Is Regulatory Evidence
A pharmaceutical clean room HVAC system does not just supply conditioned air — it provides the physical environment in which product quality is protected, and the validation evidence that demonstrates this protection meets regulatory requirements. The engineering and the validation are inseparable.
The facilities that approach pharmaceutical HVAC as engineering-plus-validation from design inception — where the validation protocol is drafted alongside the P&ID, where the EM sample points are located during HVAC layout, where the smoke visualisation is modelled before construction — are the facilities that pass regulatory inspections without observations. The ones that treat validation as an afterthought pay for it in remediation costs and delayed product launch.
Designing a Pharmaceutical Clean Room Facility?
KVRM provides pharmaceutical HVAC design and validation — GMP grade zoning, UDAF system design, CFD airflow modelling, IQ/OQ/PQ protocol development, and regulatory submission support to EU GMP Annex 1 (2022) and Schedule M.
Request a Free Consultation →